Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Teger-Nilsson

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Thrombosis Research|November 1, 1974
Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogenA C Teger-Nilsson, H Ekelund
Thrombosis Research|August 1, 1974
Rate of thrombin-fibrinogen reaction in some mammalian speciesA C Teger-Nilsson, B Blombäck
Thrombosis Research|July 1, 1980
Activity of the alpha 2-macroglobulin-plasmin complex on the plasmin specific substrate H-D-Val-Leu-Lys-p-nitroanilideE Gyzander, A C Teger-Nilsson
Thrombosis Research|January 1, 1974
A search for fibrinopeptides in urine during experimental intravascular coagulation in dogsA C Teger-Nilsson, N J Gröndahl
Vox Sanguinis|January 1, 1976
Incidence of viral hepatitis after administration of factor IX concentratesS Iwarson, H Kjellman, A C Teger-Nilsson
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1984
Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturitionL Wallmo, K Karlsson, A C Teger-Nilsson
Thrombosis Research|September 1, 1984
A sensitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-sepharoseE Gyzander, E Eriksson, A C Teger-Nilsson
Lakartidningen|November 21, 1979
[What is the cause of high plasma levels of liver-synthetized coagulation factors?]R Arnman, R Olsson, A C Teger-Nilsson
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1977
Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateA C Teger-Nilsson, P Friberger, E Gyzander
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1982
Prostacyclin infusion during extracorporeal circulation foe coronary bypassK Rådegran, C Arén, A C Teger-Nilsson
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Thrombosis Research|November 1, 1974
Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogenA C Teger-Nilsson, H Ekelund
Thrombosis Research|August 1, 1974
Rate of thrombin-fibrinogen reaction in some mammalian speciesA C Teger-Nilsson, B Blombäck
Thrombosis Research|July 1, 1980
Activity of the alpha 2-macroglobulin-plasmin complex on the plasmin specific substrate H-D-Val-Leu-Lys-p-nitroanilideE Gyzander, A C Teger-Nilsson
Thrombosis Research|January 1, 1974
A search for fibrinopeptides in urine during experimental intravascular coagulation in dogsA C Teger-Nilsson, N J Gröndahl
Vox Sanguinis|January 1, 1976
Incidence of viral hepatitis after administration of factor IX concentratesS Iwarson, H Kjellman, A C Teger-Nilsson
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1984
Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturitionL Wallmo, K Karlsson, A C Teger-Nilsson
Thrombosis Research|September 1, 1984
A sensitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-sepharoseE Gyzander, E Eriksson, A C Teger-Nilsson
Lakartidningen|November 21, 1979
[What is the cause of high plasma levels of liver-synthetized coagulation factors?]R Arnman, R Olsson, A C Teger-Nilsson
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1977
Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateA C Teger-Nilsson, P Friberger, E Gyzander
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1982
Prostacyclin infusion during extracorporeal circulation foe coronary bypassK Rådegran, C Arén, A C Teger-Nilsson
Pageof 6